Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
TRANDOLAPRIL
Abbott Laboratories Ireland Ltd
TRANDOLAPRIL
1.0 Milligram
Capsules Hard
Product subject to prescription which may be renewed (B)
Authorised
0000-00-00
PATIENT INFORMATION LEAFLET ODRIK 0.5 MG HARD CAPSULES ODRIK 1 MG HARD CAPSULES ODRIK 2 MG HARD CAPSULES Trandolapril IMPORTANT INFORMATION Please read this leaflet carefully before you start taking your medicine. Keep this leaflet as you may need to read it again. This leaflet provides a summary of the information currently available on Odrik. For further information or advice ask your doctor or pharmacist. This medicine is for you and should never be given to anyone else, even if they appear to have the same symptoms as you. Tell your doctor or pharmacist if you experience any side effects. In this leaflet: 1. What Odrik is and what it is used for 2. Before you take Odrik 3. How to take Odrik 4. Possible Side Effects 5. How to store Odrik 6. Further Information 1. WHAT ODRIK IS AND WHAT IT IS USED FOR Odrik capsules contain the active ingredient trandolapril which belongs to a group of medicines called angiotensin-converting enzyme inhibitors (ACE inhibitors). They work by relaxing the blood vessels, making it easier for the heart to pump blood around the body and lowering blood pressure. Odrik Capsules are used to treat hypertension (high blood pressure). The capsules may also be prescribed to protect the heart after a heart attack. 2. BEFORE YOU TAKE ODRIK DO NOT TAKE ODRIK IF YOU: - are ALLERGIC (hypersensitive) to trandolapril or any of the other ingredients in this medicine. - have ever had an ALLERGIC REACTION to any ACE inhibitors such as swelling of the face, lips, tongue or throat with difficulty swallowing or breathing. - have ever had the condition known as angioedema or Quincke’s oedema involving a skin condition and swelling mainly affecting the face, extremities, tongue, mouth and throat. - if you are more than 3 months PREGN Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Odrik 1mg Hard Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each hard capsule contains 1.0 mg of trandolapril. Excipients: Each hard capsule contains 55.5mg lactose monohydrate. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Hard capsule (capsule) Opaque red/orange capsule. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS All grades of essential hypertension. Odrik may be used alone or in combination with other antihypertensive agents. Left Ventricular Dysfunction after Myocardial Infarction: It has been demonstrated that Odrik improves survival following myocardial infarction in patients with left ventricular dysfunction (ejection fraction < 35 percent), with or without symptoms of heart failure, and/or, with or without residual ischaemia. Long term treatment with Odrik reduces significantly the overall mortality, especially from cardiovascular mortality. It significantly decreases the risk of sudden death and the occurrence of severe or resistant heart failure, and tends to decrease the incidence of fatal and non-fatal re-infarctions. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION ADULTS _Hypertension_ The starting dose is 1 mg once daily as a single dose. The daily dose can be adjusted according to patient response up to a maximum 4 mg given as a single daily dose. _Left ventricular dysfunction after myocardial infarction_ Following a myocardial infarction, therapy may be initiated as early as the third day. Treatment should be initiated as a daily dose of 0.5 mg. The dose should be progressively increased to a maximum of 4 mg as a single daily dose. Depending upon the tolerability such as symptomatic hypotension, this forced titration can be temporarily suspended. In the event of hy Read the complete document